681465-98-5

Basic information

• Product Name: Benzoic acid, 4-[[[(1S)-2-methoxy-1-methyl-2-oxoethyl](2-methylpropyl)amino]carbonyl ]-2-(1-methylethoxy)-
• CAS NO: 681465-98-5
• Molecular Formula: C19H27NO6
• Molecular Weight: 365.426
• Mol File: 681465-98-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 4-[[[(1S)-2-methoxy-1-methyl-2-oxoethyl](2-methylpropyl)amino]carbonyl ]-2-(1-methylethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-[[[(1S)-2-methoxy-1-methyl-2-oxoethyl](2-methylpropyl)amino]carbonyl ]-2-(1-methylethoxy)-(681465-98-5)
• EPA Substance Registry System: Benzoic acid, 4-[[[(1S)-2-methoxy-1-methyl-2-oxoethyl](2-methylpropyl)amino]carbonyl ]-2-(1-methylethoxy)-(681465-98-5)

Safety Data

• Hazardous Substances Data: 681465-98-5(Hazardous Substances Data)

Upstream product

• 681465-96-3 (S)-2-[Isobutyl-(3-isopropoxy-4-vinyl-benzoyl)-amino]-propionic acid methyl ester 
• 681465-89-4 3-isopropoxy-4-vinylbenzoic acid methyl ester 
• 681465-85-0 4-amino-3-isopropoxybenzoic acid methyl ester 
• 681465-87-2 4-iodo-3-isopropoxybenzoic acid methyl ester 
• 852065-42-0 3-isopropoxy-4-vinylbenzoic acid 
• 63435-16-5 3-hydroxy-4-aminobenzoic acid methyl ester 
• 19648-66-9 (S)-2-isobutylaminopropionic acid methyl ester 

Downstream Products

• 681466-00-2 (S)-2-{4-[isobutyl-((S)-1-methoxycarbonylethyl)carbamoyl]-2-isopropoxybenzoylamino}-4-methylpentanoic acid methyl ester 

Relevant articles and documents

Terephthalamide peptidomimetic compounds and methods

The present invention relates to compounds and pharmaceutical compositions based upon terephthalamide which are proteomimetic and to methods for inhibiting the interaction of an alpha-helical protein with another protein or binding site. Methods for treat

Terephthalamide derivatives as mimetics of the helical region of Bak peptide target Bcl-xL protein

A group of novel Bcl-xL/Bak antagonists, based on a terephthalamide scaffold, were designed to mimic the α-helical region of the Bak peptide. Good in vitro inhibition potencies in disrupting the Bak/Bcl-xL complex have been observed (terephthalamide 4, K